Thyrocare Technologies Limited has informed the Exchange about Copy of Newspaper Publication of Audited financial results for the quarter and year ended March 31, 2026
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies has published its audited financial results for Q4 and full year ended March 31, 2026. Total income from operations grew to Rs. 846.03 Crore in FY26 from Rs. 702.18 Crore in FY25, a 20% increase. Profit After Tax nearly doubled to Rs. 162.85 Crore from Rs. 90.75 Crore in the previous year. EBITDA improved significantly to Rs. 217.65 Crore versus Rs. 146.88 Crore. EPS for the year stands at Rs. 10.27 compared to Rs. 5.70 in FY25. The Board has recommended a final dividend of Rs. 7 per share for FY 2025-26. The statutory auditors have issued an unmodified audit opinion on these results.
Strong financial performance with near-doubling of profits signals solid execution. The 20% revenue growth and improved margins are positive for shareholders. The dividend declaration reinforces confidence in the company's cash generation ability.